Page last updated: 2024-08-21

isoxazoles and ticlopidine

isoxazoles has been researched along with ticlopidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borgdorff, P; Paulus, WJ; Tangelder, GJ1
Crain, EJ; Knabb, RM; Lam, PY; Quan, ML; Watson, CA; Wexler, RR; Wong, PC1
Greenhaw, J; Salminen, WF; Shi, Q; Yang, X1
Chen, F; Cheng, G; Fang, Y; Guo, Y; Li, H; Liu, D; Liu, F; Liu, L; Liu, Z; Margetts, P; Tang, L; Zhao, Z1
Cai, GY; Chen, XM; Duan, SW; Huang, W; Jia, Q; Li, JJ; Li, WG; Li, XM; Liu, SW; Liu, WH; Lun, LD; Ma, L; Sun, XF; Wang, YP; Wu, H; Wu, J; Xie, YS; Zhang, JR; Zhou, CH1

Trials

2 trial(s) available for isoxazoles and ticlopidine

ArticleYear
Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Nephrology (Carlton, Vic.), 2015, Volume: 20, Issue:2

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Biomarkers; China; Clopidogrel; Creatinine; Disease Progression; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Isoxazoles; Kidney; Leflunomide; Male; Platelet Aggregation Inhibitors; Proteinuria; Tetrazoles; Ticlopidine; Time Factors; Treatment Outcome; Valine; Valsartan

2015
Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.
    Chinese medical journal, 2016, Aug-20, Volume: 129, Issue:16

    Topics: Adolescent; Adult; Benzimidazoles; Benzoates; Blood Pressure; China; Clopidogrel; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Isoxazoles; Kidney Function Tests; Leflunomide; Male; Middle Aged; Prospective Studies; Telmisartan; Ticlopidine; Treatment Outcome; Uric Acid; Young Adult

2016

Other Studies

3 other study(ies) available for isoxazoles and ticlopidine

ArticleYear
Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation.
    Journal of the American College of Cardiology, 2006, Aug-15, Volume: 48, Issue:4

    Topics: Animals; Aspirin; Clopidogrel; Coronary Artery Bypass; Coronary Stenosis; Cyclooxygenase Inhibitors; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Risk Factors; Shear Strength; Thrombosis; Ticlopidine

2006
Razaxaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel improves low-dose antithrombotic activity without enhancing bleeding liability in rabbits.
    Journal of thrombosis and thrombolysis, 2007, Volume: 24, Issue:1

    Topics: Animals; Aspirin; Blood Coagulation; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Factor Xa; Fibrinolytic Agents; Hemorrhage; Hemostasis; Isoxazoles; Male; Platelet Aggregation; Pyrazoles; Rabbits; Thrombosis; Ticlopidine

2007
Hepatic cytochrome P450s attenuate the cytotoxicity induced by leflunomide and its active metabolite A77 1726 in primary cultured rat hepatocytes.
    Toxicological sciences : an official journal of the Society of Toxicology, 2011, Volume: 122, Issue:2

    Topics: Aniline Compounds; Animals; Benzoflavones; Biomarkers; Cell Survival; Cells, Cultured; Crotonates; Cytochrome P-450 Enzyme System; Hepatocytes; Hydroxybutyrates; Inactivation, Metabolic; Isoxazoles; Ketoconazole; Leflunomide; Liver; Male; Nitriles; Primary Cell Culture; Proadifen; Rats; Rats, Sprague-Dawley; Ticlopidine; Toluidines; Triazoles

2011